Clemastine and hyperthermia enhance sensitization of osteosarcoma cells for apoptosis

References

• Mirabello L, Troisi RJ, Savage SA. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer. 2009;125(1):229–13. doi:10.1002/ijc.24320.
   PubMed Web of Science ®Google Scholar
• Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am. 1986;68(9):1331–1337. doi:10.2106/00004623-198668090-00005.
   PubMedGoogle Scholar
• Misaghi A, Goldin A, Awad M, Kulidjian AA. Osteosarcoma: a comprehensive review. Sicot J. 2018;4:12. doi:10.1051/sicotj/2017028.
   PubMed Web of Science ®Google Scholar
• Bicher HI, Hetzel FW, Sandhu TS, Frinak S, Vaupel P, O’Hara MD, O’Brien T. Effects of hyperthermia on normal and tumor microenvironment. Radiol. 1980;137(2):523–530. doi:10.1148/radiology.137.2.7433686.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Weng S, Yu L, Zhu N, Yang M, Yuan Y. The role of hyperthermia in the multidisciplinary treatment of malignant tumors. Integr Cancer Ther. 2019;18:1534735419876345. doi:10.1177/1534735419876345.
   Web of Science ®Google Scholar
• Fajardo LF, Schreiber AB, Kelly NI, Hahn GM. Thermal sensitivity of endothelial cells. Radiat Res. 1985;103(2):276–285. doi:10.2307/3576582.
   PubMed Web of Science ®Google Scholar
• Hurwitz M, Stauffer P. Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care. Semin Oncol. 2014;41(6):714–729. doi:10.1053/j.seminoncol.2014.09.014.
   PubMed Web of Science ®Google Scholar
• Horseman M, Panahi L, Udeani G, Tenpas AS, Verduzco R Jr., Patel PH, Bazan DZ, Mora A, Samuel N, Mingle AC. et al. Drug-induced hyperthermia review. Cureus. 2022;14:e27278. doi:10.7759/cureus.27278.
   PubMedGoogle Scholar
• Imashiro C, Jin Y, Hayama M, Yamada TG, Funahashi A, Sakaguchi K, Umezu S, Komotori J. Titanium culture vessel presenting temperature gradation for the thermotolerance estimation of cells. Cyborg Bionic Syst. 2023;4:0049. doi:10.34133/cbsystems.0049.
   PubMedGoogle Scholar
• Maduabuchi WO, Tansi FL, Heller R, Hilger I. Hyperthermia influences the secretion signature of tumor cells and affects endothelial cell sprouting. Biomed. 2023;11(8):2256. doi:10.3390/biomedicines11082256.
   Google Scholar
• Xi P, Ma X, Hu F, Li L, Liu H, Zhou J, Wu W. ROS-Sp1 axis is involved in thermochemotherapy-enhanced sensitivity of pancreatic cancer cells to gemcitabine. Cell Biol Int. 2023;47(11):1825–1834. doi:10.1002/cbin.12073.
   PubMed Web of Science ®Google Scholar
• Hiramoto RN, Ghanta VK, Lilly MB. Reduction of tumor burden in a murine osteosarcoma following hyperthermia combined with cyclophosphamide. Cancer Res. 1984;44:1405–1408.
   PubMed Web of Science ®Google Scholar
• Tancredi A, Ciuffreda L, Cuttitta A, Scaramuzzi R, Sabatino R, Scaramuzzi G. Hyperthermia in the treatment of post-actinic osteosarcomas: our anecdotal experience. Eurasian J Med. 2011;43(2):115–118. doi:10.5152/eajm.2011.25.
   PubMedGoogle Scholar
• Reinhold HS, Endrich B. Tumour microcirculation as a target for hyperthermia. Int J Hyperthermia. 1986;2(2):111–137. doi:10.3109/02656738609012389.
   PubMedGoogle Scholar
• Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, Abdel-Rahman S, Daugaard S, Salat C, Wendtner CM. et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol. 2010;11(6):561–570. doi:10.1016/S1470-2045(10)70071-1.
   PubMed Web of Science ®Google Scholar
• Alcaide M, Ramirez-Santillan C, Feito MJ, de la Concepción Matesanz M, Ruiz-Hernandez E, Arcos D, Vallet-Regi M, Portoles MT. In vitro evaluation of glass–glass ceramic thermoseed-induced hyperthermia on human osteosarcoma cell line. J Biomed Mater Res A. 2012;100A(1):64–71. doi:10.1002/jbm.a.33229.
   Web of Science ®Google Scholar
• Trieb K, Blahovec H, Kubista B. Effects of hyperthermia on heat shock protein expression, alkaline phosphatase activity and proliferation in human osteosarcoma cells. Cell Biochem Funct. 2007;25(6):669–672. doi:10.1002/cbf.1371.
   PubMed Web of Science ®Google Scholar
• Shui C, Scutt A. Mild heat shock induces proliferation, alkaline phosphatase activity, and mineralization in human bone marrow stromal cells and Mg-63 cells in vitro. J Bone Miner Res. 2001;16(4):731–741. doi:10.1359/jbmr.2001.16.4.731.
   PubMed Web of Science ®Google Scholar
• Hou CH, Lin FL, Hou SM, Liu JF. Hyperthermia induces apoptosis through endoplasmic reticulum and reactive oxygen species in human osteosarcoma cells. Int J Mol Sci. 2014;15(10):17380–17395. doi:10.3390/ijms151017380.
   PubMed Web of Science ®Google Scholar
• Nakajima K, Yanagawa T, Watanabe H, Takagishi K. Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor. Oncol Rep. 2012;28(6):1953–1958. doi:10.3892/or.2012.2066.
   PubMed Web of Science ®Google Scholar
• Shido Y, Nishida Y, Suzuki Y, Kobayashi T, Ishiguro N. Targeted hyperthermia using magnetite cationic liposomes and an alternating magnetic field in a mouse osteosarcoma model. J Bone Joint Surg Br. 2010;92-B(4):580–585. doi:10.1302/0301-620X.92B4.22814.
   Google Scholar
• Seynhaeve ALB, Amin M, Haemmerich D, van Rhoon GC, Ten Hagen TLM. Hyperthermia and smart drug delivery systems for solid tumor therapy. Adv Drug Deliv Rev. 2020;163-164:125–144. doi:10.1016/j.addr.2020.02.004.
   PubMed Web of Science ®Google Scholar
• Nair MP, Schwartz SA. Effect of histamine and histamine antagonists on natural and antibody-dependent cellular cytotoxicity of human lymphocytes in vitro. Cell Immunol. 1983;81(1):45–60. doi:10.1016/0008-8749(83)90210-1.
   PubMed Web of Science ®Google Scholar
• Nguyen PL, Cho J. Pathophysiological roles of histamine receptors in cancer progression: implications and perspectives as potential molecular targets. Biomolecul. 2021;11(8):1232. doi:10.3390/biom11081232.
   PubMed Web of Science ®Google Scholar
• Zhao J, Hou Y, Yin C, Hu J, Gao T, Huang X, Zhang X, Xing J, An J, Wan S. et al. Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma. Oncogene. 2020;39(8):1724–1738. doi:10.1038/s41388-019-1093-y.
   PubMed Web of Science ®Google Scholar
• Nakano K. Challenges of systemic therapy investigations for bone sarcomas. Int J Mol Sci. 2022;23(7):3540. doi:10.3390/ijms23073540.
   PubMed Web of Science ®Google Scholar
• Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K/Akt/mTOR pathway and its role in cancer therapeutics: are we making headway? Front Oncol. 2022;12:819128. doi:10.3389/fonc.2022.819128.
   PubMed Web of Science ®Google Scholar
• Varshney P, Saini N. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis. Biochim Biophys Acta Mol Basis Dis. 2018;1864(5):1795–1803. doi:10.1016/j.bbadis.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Heckmann BL, Yang X, Zhang X, Liu J. The autophagic inhibitor 3-methyladenine potently stimulates PKA-dependent lipolysis in adipocytes. Br J Pharmacol. 2013;168:163–171. doi:10.1111/j.1476-5381.2012.02110.x.
   PubMed Web of Science ®Google Scholar
• Biermann JS, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Butrynski JE, Cheong D, Chow W, Curry WT, Frassica DA. et al. Bone cancer. J Natl Compr Canc Netw. 2013;11(6):688–723. doi:10.6004/jnccn.2013.0088.
   PubMed Web of Science ®Google Scholar
• Lindsey BA, Markel JE, Kleinerman ES. Osteosarcoma overview. Rheumatol Ther. 2017;4(1):25–43. doi:10.1007/s40744-016-0050-2.
   PubMed Web of Science ®Google Scholar
• Hughes DP. Strategies for the targeted delivery of therapeutics for osteosarcoma. Expert Opin Drug Deliv. 2009;6(12):1311–1321. doi:10.1517/17425240903280422.
   PubMed Web of Science ®Google Scholar
• Bacci G, Longhi A, Bertoni F, Briccoli A, Versari M, Pignotti E, Picci P. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy the Rizzoli experience in 52 patients. Acta Orthop. 2006;77(6):938–943. doi:10.1080/17453670610013268.
   PubMed Web of Science ®Google Scholar
• PosthumaDeboer J, Witlox MA, Kaspers GJ, van Royen BJ. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin Exp Metastasis. 2011;28(5):493–503. doi:10.1007/s10585-011-9384-x.
   PubMed Web of Science ®Google Scholar
• Pungsrinont T, Kallenbach J, Baniahmad A. Role of PI3K-AKT-mTOR pathway as a pro-survival signaling and resistance-mediating mechanism to therapy of prostate cancer. Int J Mol Sci. 2021;22(20):11088. doi:10.3390/ijms222011088.
   PubMed Web of Science ®Google Scholar
• Tian LY, Smit DJ, Jucker M. The role of PI3K/AKT/mTOR signaling in hepatocellular carcinoma metabolism. Int J Mol Sci. 2023;24(3):2652. doi:10.3390/ijms24032652.
   PubMed Web of Science ®Google Scholar
• Paplomata E, O’Regan R. The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers. Ther Adv Med Oncol. 2014;6(4):154–166. doi:10.1177/1758834014530023.
   PubMed Web of Science ®Google Scholar
• Ding L, Congwei L, Bei Q, Tao Y, Ruiguo W, Heze Y, Bo D, Zhihong L. mTOR: an attractive therapeutic target for osteosarcoma? Oncotarget. 2016;7(31):50805–50813. doi:10.18632/oncotarget.9305.
   PubMedGoogle Scholar
• He C, Klionsky DJ. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet. 2009;43(1):67–93. doi:10.1146/annurev-genet-102808-114910.
   PubMed Web of Science ®Google Scholar
• Kim KW, Mutter RW, Cao C, Albert JM, Freeman M, Hallahan DE, Lu B. Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J Biol Chem. 2006;281:36883–36890. doi:10.1074/jbc.M607094200.
   PubMed Web of Science ®Google Scholar
• Verschooten L, Barrette K, Van Kelst S, Rubio Romero N, Proby C, De Vos R, Agostinis P, Garmyn M, Koul H. Autophagy inhibitor chloroquine enhanced the cell death inducing effect of the flavonoid luteolin in metastatic squamous cell carcinoma cells. PLOS ONE. 2012;7(10):e48264. doi:10.1371/journal.pone.0048264.
   PubMed Web of Science ®Google Scholar
• Yorimitsu T, Klionsky DJ. Autophagy: molecular machinery for self-eating. Cell Death Differ. 2005;12(Suppl S2):1542–1552. doi:10.1038/sj.cdd.4401765.
   PubMedGoogle Scholar
• O’Farrell F, Wang S, Katheder N, Rusten TE, Samakovlis C, Nusse R. Two-tiered control of epithelial growth and autophagy by the insulin receptor and the ret-like receptor, stitcher. PLOS Biol. 2013;11(7):e1001612. doi:10.1371/journal.pbio.1001612.
   PubMed Web of Science ®Google Scholar
• Scott RC, Juhasz G, Neufeld TP. Direct induction of autophagy by Atg1 inhibits cell growth and induces apoptotic cell death. Curr Biol. 2007;17(1):1–11. doi:10.1016/j.cub.2006.10.053.
   PubMed Web of Science ®Google Scholar
• Rodon J, Dienstmann R, Serra V, Tabernero J. Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol. 2013;10(3):143–153. doi:10.1038/nrclinonc.2013.10.
   PubMed Web of Science ®Google Scholar
• Arcaro A, Wymann MP. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J. 1993;296(2):297–301. doi:10.1042/bj2960297.
   PubMedGoogle Scholar
• Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, Ong CN, Codogno P, Shen HM. Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 2010;285:10850–10861. doi:10.1074/jbc.M109.080796.
   PubMed Web of Science ®Google Scholar
• Aliabadi F, Sohrabi B, Mostafavi E, Pazoki-Toroudi H, Webster TJ. Ubiquitin–proteasome system and the role of its inhibitors in cancer therapy. Open Biol. 2021;11(4):200390. doi:10.1098/rsob.200390.
   PubMed Web of Science ®Google Scholar